IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 325
Titolo Data di pubblicazione Autore(i) File
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis 1-gen-2008 Stroffolini, T.; Almasio, P. L.; Persico, M.; Bollani, S.; Benvegnù, L.; Di Costanzo, G.; Pastore, G.; Aghemo, A.; Stornaiuolo, G.; Mangia, A.; Andreone, P.; Stanzione, M.; Mazzella, G.; Saracco, G.; Del Poggio, P.; Bruno, S.; Association of the Study of the Liver Disease, Italian
Optimizing treatment with pegylated interferon-ribavirin of genotype 3 chronic hepatitis C : more questions than answers 1-gen-2008 Aghemo, A.; D’Ambrosio, R.; Rumi, M. G.; Colombo, M.
Recovery after L-DOPA treatment in peg-interferon and ribavirin induced parkinsonism 1-gen-2008 Bersano, A.; Aghemo, A.; Rumi, M.; Ballabio, E.; Candelise, L.; Colombo, M.
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics? 1-gen-2008 Aghemo, A; Rumi, Mg; Colombo, M
The natural history of hepatic macroregenerative nodules developing in cirrhotic patients during surveillance with ultrasound (US) 1-gen-2009 Sangiovanni, A.; Della Corte, C.; Manini, M. A.; Iavarone, M.; Vavassori, S.; Romeo, R.; Fraquelli, M.; Forzenigo, L. V.; Ronchi, G.; Aghemo, A.; Colombo, M.
Prospective study of dysplastic nodules in cirrhosis : correlation with CT vascular pattern, histology and development of hepatocellular carcinoma 1-gen-2009 Iavarone, M.; Sangiovanni, A.; Ronchi, G.; Forzenigo, L. V.; Aghemo, A.; Lampertico, P.; Colombo., M.
In vivo and in vitro effect of ribavirin and interferon on erythropoiesis in patients with hepatitis C 1-gen-2009 Ronzoni, L.; Colancecco, A.; Cattaneo, A.; Aghemo, A.; Monico, S.; Rumi, M.; Colombo, M.; Cappellini, M. D.
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 1-gen-2009 Aghemo, A.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; De Nicola, S.; Colombo, M.
Interferoni pegilati nel trattamento dei pazienti con epatite cronica HCV : esperienze a confronti 1-gen-2009 Rumi, M. G.; Aghemo, A.; Prati, G. M.; D’Ambrosio, R.
In vivo and in vitro effect of ribavirin and pegylated-interferon on erythropoiesis in patients with hepatitis C 1-gen-2009 Ronzoni, L.; Aghemo, A.; Colancecco, A.; Cattaneo, A.; Rumi, M.; Colombo, M.; Cappellini, M. D.
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegykated interferon-α2A in chronic hepatitis C : an in vitro and in vivo study 1-gen-2009 Prati, G. M.; Aghemo, A.; Ronzoni, L.; Rumi, M.; Monico, S.; Colancecco, A.; Grillo, P.; Viganò, M.; Cappellini, M.; Colombo, M.
Prospective study of dysplastic nodules in cirrhosis : correlation with CT vascular pattern, histology and development of hepatocellular carcinoma 1-gen-2009 Iavarone, M.; Sangiovanni, A.; Ronchi, G.; Forzenigo, L. V.; Aghemo, A.; Lampertico, P.; Colombo, M.
The influence of liver fibrosis on the outcome of pegylated interferon and ribavirin anti-hac therapy : a sub-analysis of the mist study 1-gen-2009 Prati, G. M.; Rumi, M.; Aghemo, A.; D’Ambrosio, R.; De Nicola, S.; Colombo, M.
Evaluation of liver disease in a cohort of patients affected by thalassemia intermedia 1-gen-2009 Motta, I.; Rumi, M. G.; Cesaretti, C.; Aghemo, A.; Fraquelli, M.; Roghi, A.; Cappellini, M. D.
Cirrhosis regression in chronic hepatitis C: an old tale with a new ending. 1-gen-2009 Aghemo, A; Colombo, M.
Prevalence of psychiatric disorders during PEG – Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated 1-gen-2009 Dell’Osso, B. M.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; Balossi, I.; D’Urso, N.; Castellano, F.; Palazzo, M.; Colombo, M.; Altamura, A. C.; Aghemo, A. M.
Treatment of nonresponder patients with chronic hepatitis C : To repeat or not to repeat? that is the question 1-gen-2009 Aghemo, A.; Colombo, M.
The pattern of pegylated interferon-alpha 2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype 1-gen-2009 Aghemo, A; Rumi, Mg; Monico, S; Prati, Gm; D'Ambrosio, R; Donato, Mf; Colombo, M
High levels of factor VIII and risk of extra-hepatic portal vein obstruction 1-gen-2009 Martinelli, I.; Primignani, M.; Aghemo, A.; Reati, R.; Bucciarelli, P.; Fabris, F.; Battaglioli, T.; Dell'Era, A.; Mannucci, P. M.
Pegylated IFN-alpha 2a and ribavirin in the treatment of hepatitis C 1-gen-2009 Aghemo, A.; Rumi, M. G.; Colombo, M.
Mostrati risultati da 21 a 40 di 325
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile